Alterity Therapeutics (ATHE) Treasury Shares (2010 - 2011)
Alterity Therapeutics (ATHE) recorded quarterly Treasury Shares of $292.3 million in Q2 2011, up 41.26% quarter-over-quarter from $206.9 million in Q2 2010, and up 41.26% on a YoY basis from $206.9 million in Q2 2010.
Alterity Therapeutics (ATHE) Treasury Shares (2010 - 2011) Analysis & Trends
Alterity Therapeutics' Treasury Shares history runs 2 years deep, the most recent figure standing at $292.3 million for Q2 2011.
- In Q2 2011, Treasury Shares rose 41.26% year-over-year to $292.3 million; the TTM figure through Jun 2011 stood at $292.3 million (up 41.26% YoY), while the FY2011 annual figure was $292.3 million, up 41.26% from the prior year.
- Treasury Shares was $292.3 million for Q2 2011 at Alterity Therapeutics, up from $206.9 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $292.3 million in Q2 2011 to a low of $206.9 million in Q2 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | 34.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2011 | 292.27 Mn |
| Jun 30, 2011 | 292.27 Mn |
| Jun 30, 2010 | 206.91 Mn |
| Jun 30, 2010 | 206.91 Mn |